Peptides Containing meso‐Oxa‐Diaminopimelic Acid as Substrates for the Cell‐Shape‐Determining Proteases Csd6 and Pgp2

The enzymes Csd6 and Pgp2 are peptidoglycan (PG) proteases found in the pathogenic bacteria Helicobacter pylori and Campylobacter jejuni, respectively. These enzymes are involved in the trimming of non‐crosslinked PG sidechains and catalyze the cleavage of the bond between meso‐diaminopimelic acid (meso‐Dap) and d‐alanine, thus converting a PG tetrapeptide into a PG tripeptide. They are known to be cell‐shape‐determining enzymes, because deletion of the corresponding genes results in mutant strains that have lost the normal helical phenotype and instead possess a straight‐rod morphology. In this work, we report two approaches directed towards the synthesis of the tripeptide substrate Ac‐iso‐d‐Glu‐meso‐oxa‐Dap‐d‐Ala, which serves as a mimic of the terminus of an non‐crosslinked PG tetrapeptide substrate. The isosteric analogue meso‐oxa‐Dap was utilized in place of meso‐Dap to simplify the synthetic procedure. The more efficient synthesis involved ring opening of a peptide‐embedded aziridine by a serine‐based nucleophile. A branched tetrapeptide was also prepared as a mimic of the terminus of a crosslinked PG tetrapeptide. We used MS analysis to demonstrate that the tripeptide serves as a substrate for both Csd6 and Pgp2 and that the branched tetrapeptide serves as a substrate for Pgp2, albeit at a significantly slower rate.

[1]  Y. Brun,et al.  The Molecular Basis of Noncanonical Bacterial Morphology. , 2017, Trends in microbiology.

[2]  M. Stahl,et al.  The Helical Shape of Campylobacter jejuni Promotes In Vivo Pathogenesis by Aiding Transit through Intestinal Mucus and Colonization of Crypts , 2016, Infection and Immunity.

[3]  Frederick C. Neidhardt,et al.  Escherichia coli and Salmonella :cellular and molecular biology , 2016 .

[4]  M. Murphy,et al.  A Bacterial Cell Shape-Determining Inhibitor. , 2016, ACS chemical biology.

[5]  K. Fukase,et al.  Synthesis of characteristic Mycobacterium peptidoglycan (PGN) fragments utilizing with chemoenzymatic preparation of meso-diaminopimelic acid (DAP), and their modulation of innate immune responses. , 2016, Organic & biomolecular chemistry.

[6]  Nam Ki Lee,et al.  The Cell Shape-determining Csd6 Protein from Helicobacter pylori Constitutes a New Family of l,d-Carboxypeptidase , 2015, The Journal of Biological Chemistry.

[7]  T. Donohoe,et al.  Aziridine electrophiles in the functionalisation of peptide chains with amine nucleophiles. , 2015, Organic & biomolecular chemistry.

[8]  M. Murphy,et al.  Helical Shape of Helicobacter pylori Requires an Atypical Glutamine as a Zinc Ligand in the Carboxypeptidase Csd4* , 2014, The Journal of Biological Chemistry.

[9]  F. Cava,et al.  Peptidoglycan plasticity in bacteria: emerging variability of the murein sacculus and their associated biological functions. , 2014, Current opinion in microbiology.

[10]  Christopher J. White,et al.  Site-specific integration of amino acid fragments into cyclic peptides. , 2014, Journal of the American Chemical Society.

[11]  S. Foster,et al.  Different walls for rods and balls: the diversity of peptidoglycan , 2014, Molecular microbiology.

[12]  Michael E. Taveirne,et al.  Peptidoglycan ld-Carboxypeptidase Pgp2 Influences Campylobacter jejuni Helical Cell Shape and Pathogenic Properties and Provides the Substrate for the dl-Carboxypeptidase Pgp1* , 2014, The Journal of Biological Chemistry.

[13]  E. Gaynor,et al.  Peptidoglycan hydrolases, bacterial shape, and pathogenesis. , 2013, Current opinion in microbiology.

[14]  T. Petersen,et al.  Flow cytometry-based enrichment for cell shape mutants identifies multiple genes that influence Helicobacter pylori morphology , 2013, Molecular microbiology.

[15]  Jennifer A. Taylor,et al.  Beyond growth: novel functions for bacterial cell wall hydrolases. , 2012, Trends in microbiology.

[16]  S. Girardin,et al.  Peptidoglycan-Modifying Enzyme Pgp1 Is Required for Helical Cell Shape and Pathogenicity Traits in Campylobacter jejuni , 2012, PLoS pathogens.

[17]  W. Vollmer,et al.  Multiple Peptidoglycan Modification Networks Modulate Helicobacter pylori's Cell Shape, Motility, and Colonization Potential , 2012, PLoS pathogens.

[18]  J. Vederas,et al.  The synthesis of active and stable diaminopimelate analogues of the lantibiotic peptide lactocin S. , 2012, Journal of the American Chemical Society.

[19]  A. Gautam,et al.  Peptidoglycan biosynthesis machinery: A rich source of drug targets , 2011, Critical reviews in biotechnology.

[20]  J. Dworkin,et al.  Synthetic Peptidoglycan Motifs for Germination of Bacterial Spores , 2010, Chembiochem : a European journal of chemical biology.

[21]  S. Guadagnini,et al.  A M23B family metallopeptidase of Helicobacter pylori required for cell shape, pole formation and virulence , 2010, Molecular microbiology.

[22]  Ki Duk Park,et al.  The structure-activity relationship of the 3-oxy site in the anticonvulsant (R)-N-benzyl 2-acetamido-3-methoxypropionamide. , 2010, Journal of medicinal chemistry.

[23]  W. Vollmer,et al.  Peptidoglycan Crosslinking Relaxation Promotes Helicobacter pylori's Helical Shape and Stomach Colonization , 2010, Cell.

[24]  J. Vederas,et al.  Synthesis and biological activity of oxa-lacticin A2, a lantibiotic analogue with sulfur replaced by oxygen. , 2009, Organic letters.

[25]  S. Mobashery,et al.  Bacterial AmpD at the crossroads of peptidoglycan recycling and manifestation of antibiotic resistance. , 2009, Journal of the American Chemical Society.

[26]  K. Fukase,et al.  Synthesis of diaminopimelic acid containing peptidoglycan fragments and tracheal cytotoxin (TCT) and investigation of their biological functions. , 2008, Chemistry.

[27]  M. de Pedro,et al.  Peptidoglycan structure and architecture. , 2008, FEMS microbiology reviews.

[28]  J. Vederas,et al.  Stereoselective syntheses of 4-oxa diaminopimelic acid and its protected derivatives via aziridine ring opening. , 2007, Organic letters.

[29]  A. van der Ende,et al.  Of microbe and man: determinants of Helicobacter pylori-related diseases. , 2006, FEMS microbiology reviews.

[30]  M. Wolfert,et al.  Synthesis and Proinflammatory Properties of Muramyl Tripeptides Containing Lysine and Diaminopimelic Acid Moieties , 2005, Chembiochem : a European journal of chemical biology.

[31]  Nathan D. Ide,et al.  Aziridine-2-carboxylic acid-containing peptides: application to solution- and solid-phase convergent site-selective peptide modification. , 2005, Journal of the American Chemical Society.

[32]  J. Butzler,et al.  Campylobacter, from obscurity to celebrity. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[33]  W. A. van der Donk,et al.  Site-selective conjugation of thiols with aziridine-2-carboxylic acid-containing peptides. , 2004, Journal of the American Chemical Society.

[34]  Andrew V. Sutherland,et al.  Conjugate addition of radicals generated from diacyloxyiodobenzenes to dehydroamino acid derivatives; a synthesis of diaminopimelic acid analogues. , 2002, Chemical communications.

[35]  V. Martín,et al.  General stereoselective synthesis of chemically differentiated alpha-diamino acids: synthesis of 2,6-diaminopimelic and 2,7-diaminosuberic acids. , 2001, The Journal of organic chemistry.

[36]  M. Toney,et al.  Evidence for a two-base mechanism involving tyrosine-265 from arginine-219 mutants of alanine racemase. , 1999, Biochemistry.

[37]  T. Lectka,et al.  “Orthogonal” Lewis Acids: Catalyzed Ring Opening and Rearrangement of Acylaziridines , 1998 .

[38]  J. Vederas,et al.  Stereoselective Synthesis of meso-2,6-Diaminopimelic Acid and Its Selectively Protected Derivatives , 1998 .

[39]  Y. Iwakura,et al.  Acid-catalyzed isomerization of 1-acyl- and 1-thioacylaziridines. I. Mechanism of nucleophilic substitution , 1969 .

[40]  H. W. Heine Umlagerungen von Aziridin‐Derivaten , 1962 .

[41]  H. Heine The Isomerization of Aziridine Derivatives , 1962 .